The study, “Structural Proteomics: An Opportunity Overview for Investors,” by John Sullivan, is now available through Multex at, for $300. The study provides an overview of the field of structural proteomics, including recent technology developments and an analysis of company valuations. Sullivan is a drug discovery analyst at Stephens.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.